CD46 and breast cancer: One study has examined the phenotypic expression pattern of CD46 isoforms in peripheral blood mononuclear leukocytes (PBMCs) in a larger population and found that 65% of the population preferentially expressed the BC isoforms, 29% had an equal distribution of the BC and the C isoforms and only 6% expressed mainly the C isoforms6.